HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sanjiv J Shah Selected Research

Natriuretic Peptides

5/2024Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial.
3/2024Correlates of Plasma NT-proBNP/Cyclic GMP Ratio in Heart Failure With Preserved Ejection Fraction: An Analysis of the RELAX Trial.
12/2023Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in Patients With Heart Failure: The DETERMINE Randomized Clinical Trials.
11/2023Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP-HF II trial.
4/2023Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial Results.
1/2023Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection Fraction.
1/2023Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype.
1/2023Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the DELIVER Trial.
1/2023Effect of dapagliflozin on health status and quality of life across the spectrum of ejection fraction: Participant-level pooled analysis from the DAPA-HF and DELIVER trials.
12/2022Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sanjiv J Shah Research Topics

Disease

232Heart Failure
05/2024 - 02/2006
50Cardiomyopathies (Cardiomyopathy)
05/2024 - 01/2017
26Atrial Fibrillation
05/2024 - 01/2014
25Inflammation (Inflammations)
02/2024 - 11/2011
23Atherosclerosis
04/2024 - 08/2013
20Hypertension (High Blood Pressure)
05/2024 - 10/2012
20Cardiovascular Diseases (Cardiovascular Disease)
04/2024 - 01/2015
19Obesity
05/2024 - 08/2017
18Heart Diseases (Heart Disease)
05/2024 - 10/2012
15Fibrosis (Cirrhosis)
03/2024 - 11/2015
13Pulmonary Hypertension
04/2024 - 07/2009
12Chronic Renal Insufficiency
12/2023 - 01/2014
11Body Weight (Weight, Body)
05/2024 - 10/2019
10Type 2 Diabetes Mellitus (MODY)
05/2024 - 01/2021
10Amyloidosis
12/2023 - 12/2016
9Hypotension (Low Blood Pressure)
12/2023 - 05/2012
9Dyspnea (Shortness of Breath)
11/2023 - 02/2007
9Systemic Scleroderma (Systemic Sclerosis)
01/2023 - 02/2010
8Left Ventricular Dysfunction
02/2024 - 02/2006
8Hyperkalemia
11/2021 - 04/2014
8Heart Arrest (Cardiac Arrest)
11/2021 - 04/2014
8Pulmonary Arterial Hypertension
10/2018 - 05/2008
7Insulin Resistance
06/2023 - 10/2016
7Diabetes Mellitus
01/2023 - 09/2009
7Infections
01/2023 - 03/2013
6Weight Loss (Weight Reduction)
01/2024 - 01/2020
6HIV Infections (HIV Infection)
12/2019 - 01/2018
5Myocardial Infarction
03/2024 - 04/2007
5Edema (Dropsy)
01/2023 - 12/2016
5Stroke (Strokes)
01/2023 - 07/2015
5Coronary Artery Disease (Coronary Atherosclerosis)
01/2021 - 01/2014
4Vascular Diseases (Vascular Disease)
04/2024 - 02/2010
4Disease Progression
02/2024 - 08/2011
4Albuminuria
11/2021 - 01/2017
4Coronary Disease (Coronary Heart Disease)
01/2020 - 01/2008
4Hypokalemia
01/2019 - 04/2014
3Transthyretin-Related Hereditary Amyloidosis
01/2022 - 06/2017
3Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 01/2016
3Necrosis
01/2022 - 04/2018
3Carotid Stenosis (Carotid Artery Stenosis)
12/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

45dapagliflozinIBA
05/2024 - 01/2021
38Brain Natriuretic Peptide (Natrecor)FDA Link
05/2024 - 02/2007
34Mineralocorticoid Receptor AntagonistsIBA
05/2024 - 03/2013
32Biomarkers (Surrogate Marker)IBA
02/2024 - 09/2009
28Natriuretic PeptidesIBA
05/2024 - 12/2015
24pro-brain natriuretic peptide (1-76)IBA
05/2024 - 10/2018
22Spironolactone (Aldactone)FDA LinkGeneric
05/2024 - 03/2013
20Glucose (Dextrose)FDA LinkGeneric
05/2024 - 01/2016
19SodiumIBA
04/2024 - 10/2013
18DiureticsIBA
05/2024 - 09/2009
17Prealbumin (Transthyretin)IBA
12/2023 - 12/2016
15sacubitril and valsartan sodium hydrate drug combinationIBA
11/2023 - 08/2016
14Amyloid (Amyloid Fibrils)IBA
12/2023 - 12/2016
14CreatinineIBA
01/2021 - 05/2008
12C-Reactive ProteinIBA
04/2024 - 02/2006
11Sodium-Glucose Transport ProteinsIBA
05/2024 - 01/2022
9semaglutideIBA
05/2024 - 01/2023
8salicylhydroxamic acid (SHAM)IBA
04/2024 - 01/2018
8paragonIBA
02/2024 - 12/2019
8Sodium-Glucose Transporter 2 InhibitorsIBA
11/2023 - 11/2017
8AlbuminsIBA
01/2021 - 02/2010
7tafamidisIBA
11/2023 - 06/2017
7Hemoglobins (Hemoglobin)IBA
07/2023 - 02/2010
7Soluble Guanylyl CyclaseIBA
10/2020 - 12/2015
6high fluorescent intermediate IIIBA
04/2024 - 01/2020
6Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
03/2024 - 01/2019
6Uric Acid (Urate)IBA
07/2023 - 01/2019
6Plasminogen Activator Inhibitor 1IBA
11/2021 - 11/2016
6vericiguatIBA
10/2020 - 12/2015
54-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA
04/2024 - 05/2011
5Insulin (Novolin)FDA Link
06/2023 - 11/2017
5Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2023 - 07/2016
5Neprilysin (Neutral Endopeptidase)IBA
12/2022 - 07/2016
5Gonadal Steroid Hormones (Sex Hormones)IBA
12/2019 - 01/2018
4SymportersIBA
04/2024 - 11/2017
4empagliflozinIBA
07/2023 - 11/2017
4NitritesIBA
01/2023 - 07/2016
4Antihypertensive Agents (Antihypertensives)IBA
01/2023 - 01/2016
4CanagliflozinIBA
01/2023 - 10/2019
4Proteins (Proteins, Gene)FDA Link
12/2022 - 11/2020
4Valsartan (Vals)FDA Link
01/2022 - 10/2019
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2016 - 04/2007
3Glucagon-Like Peptide-1 ReceptorIBA
04/2024 - 01/2023
3Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2024 - 01/2020
3Adenosine (Adenocard)FDA LinkGeneric
12/2023 - 01/2018
3Fibroblast Growth Factor-23IBA
11/2023 - 11/2020
3GadoliniumIBA
08/2023 - 08/2017
3Angiotensin Receptors (Angiotensin II Receptor)IBA
12/2022 - 08/2016
3Triglycerides (Triacylglycerol)IBA
01/2022 - 12/2019
3HDL CholesterolIBA
01/2022 - 12/2019
3CholesterolIBA
01/2022 - 01/2016
3Guanosine Monophosphate (5' Guanylic Acid)IBA
06/2021 - 07/2016
3PotassiumIBA
01/2021 - 01/2015
3NitratesIBA
11/2017 - 12/2015
3Transcription Factors (Transcription Factor)IBA
01/2017 - 11/2016

Therapy/Procedure

77Therapeutics
05/2024 - 04/2007
7Precision Medicine
01/2022 - 10/2012
3Drug Therapy (Chemotherapy)
01/2023 - 05/2016
3Patient Readmission
10/2022 - 06/2014
3Stem Cell Transplantation
11/2014 - 08/2011